Currently out of the existing stock ratings of Puneet Souda, 200 are a BUY (83.33%), 40 are a HOLD (16.67%).

Puneet Souda

Work Performance Price Targets & Ratings Chart

Analyst Puneet Souda, currently employed at LEERINK, carries an average stock price target met ratio of 67.05% that have a potential upside of 30.45% achieved within 181 days.

Puneet Souda’s has documented 461 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on MYGN, Myriad Genetics at 09-Dec-2024.

Wall Street Analyst Puneet Souda

Analyst best performing recommendations are on NVTA (INVITAE CORP).
The best stock recommendation documented was for NVTA (INVITAE CORP) at 11/9/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.72 (31.58%) receiving and performance score of 315.79.

Average potential price target upside

of $43.79 (12.63%) on TMO (THERMO FISHER SCIENTIFIC).
of $42.46 (27.03%) on RGEN (REPLIGEN).
of $37.79 (56.2%) on GH (GUARDANT HEALTH).

A Agilent Technologies ABCL Abcellera Biologics BRKR Bruker CSTL Castle Biosciences EXAS EXACT Sciences GH Guardant Health ILMN Illumina MYGN Myriad Genetics NEO NeoGenomics NTRA Natera NVTA Invitae Corp QTRX Quanterix Corp TECH Bio-Techne Corp TMO Thermo Fisher Scientific TTOO T2 Biosystms TWST Twist Bioscience Corp VCYT Veracyte WAT Waters CYRX Cryoport HOLX Hologic RGEN Repligen ISO IsoPlexis Corp MASS 908 Devices OLK Olink Holding AB ADR CNTG Centogene B V

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Derik De Bruin (BAML)